Resistance doesn’t end after kickoff—it evolves. To lead lasting transformation, CEOs must stop treating pushback as failure and start using it as fuel.

How pharma and biotech leaders can navigate today’s challenging landscape—focusing on revamped approaches in business operations, talent strategy and development, and more to meet the evolving demands.

Outlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.

BTS and its clients won 72 Brandon Hall Group Excellence Awards in 2026, the company's highest total in recent years.

La adopción de inteligencia artificial crece entre las compañías, pero convertir esta tecnología en resultados tangibles sigue siendo uno de los grandes retos empresariales.

Come utilizzare l’intelligenza artificiale in modo responsabile nelle Risorse Umane, riducendo rischi e bias e garantendo la conformità all’AI Act europeo.